LISPI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.592
AS - Asia 1.776
EU - Europa 964
SA - Sud America 253
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 46
OC - Oceania 14
Totale 5.705
Nazione #
US - Stati Uniti d'America 2.488
SG - Singapore 523
CN - Cina 483
IT - Italia 284
VN - Vietnam 212
HK - Hong Kong 195
BR - Brasile 182
GB - Regno Unito 152
SE - Svezia 141
BD - Bangladesh 109
RU - Federazione Russa 99
DE - Germania 75
KR - Corea 74
ID - Indonesia 51
CA - Canada 49
FI - Finlandia 39
FR - Francia 38
IN - India 33
AR - Argentina 24
NL - Olanda 23
MA - Marocco 16
AU - Australia 14
JP - Giappone 14
MX - Messico 14
AT - Austria 12
ES - Italia 12
LT - Lituania 12
UA - Ucraina 12
AE - Emirati Arabi Uniti 11
CO - Colombia 10
DK - Danimarca 10
CR - Costa Rica 9
EC - Ecuador 9
PL - Polonia 9
CH - Svizzera 8
CL - Cile 8
PH - Filippine 8
PK - Pakistan 8
TR - Turchia 8
BE - Belgio 7
DZ - Algeria 7
MY - Malesia 7
PY - Paraguay 7
ZA - Sudafrica 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
IE - Irlanda 6
JM - Giamaica 6
UZ - Uzbekistan 6
VE - Venezuela 6
IQ - Iraq 5
TH - Thailandia 5
TN - Tunisia 5
GP - Guadalupe 4
HN - Honduras 4
KE - Kenya 4
NI - Nicaragua 4
BO - Bolivia 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
KZ - Kazakistan 3
NP - Nepal 3
PR - Porto Rico 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
PT - Portogallo 2
SC - Seychelles 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BY - Bielorussia 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.650
Città #
Ashburn 378
Singapore 365
Santa Clara 308
Hefei 205
Hong Kong 189
San Jose 175
Council Bluffs 171
Fairfield 92
Beijing 87
London 72
Los Angeles 69
Nyköping 67
Seoul 67
Ho Chi Minh City 66
The Dalles 55
Hanoi 52
Chicago 48
New York 47
Chandler 44
Woodbridge 37
Dallas 36
Jakarta 36
Houston 35
Helsinki 31
Milan 31
Southend 28
Ann Arbor 27
Seattle 27
Wilmington 26
Cambridge 24
Salt Lake City 23
São Paulo 22
Phoenix 21
Rome 20
Boardman 18
Lauterbourg 17
Modena 17
Moscow 17
Orem 17
Buffalo 16
Munich 16
Atlanta 15
San Diego 15
Kent 14
Montreal 14
Princeton 13
Bremen 12
Brooklyn 11
Chennai 11
Columbus 11
Jacksonville 11
Naples 11
Amsterdam 10
Bologna 10
Copenhagen 10
Manchester 10
Shanghai 10
Washington 10
Darmstadt 9
Elk Grove Village 9
Settat 9
Tokyo 9
Toronto 9
Warsaw 9
Beaverton 8
Denver 8
Napoli 8
Parma 8
Tampa 8
Zurich 8
Genoa 7
Haiphong 7
Ninh Bình 7
Potenza 7
San Francisco 7
San José 7
Sydney 7
Charlotte 6
Da Nang 6
Dublin 6
Frankfurt am Main 6
Guangzhou 6
Paris 6
Sofia 6
Bari 5
Brasília 5
Brno 5
Brussels 5
Cleveland 5
Kilburn 5
Lappeenranta 5
Melbourne 5
North Bergen 5
Palermo 5
Porto Alegre 5
Redondo Beach 5
Biên Hòa 4
Dearborn 4
Florence 4
Guayaquil 4
Totale 3.566
Nome #
LH and hCG Action on the Same Receptor Results in Quantitatively and Qualitatively Different Intracellular Signalling 466
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro 318
Testosterone Serum Levels Are Related to Sperm DNA Fragmentation Index Reduction after FSH Administration in Males with Idiopathic Infertility 318
Dosing Characteristics of Recombinant Human Luteinizing Hormone or Human Menopausal Gonadotrophin-Derived LH Activity in Patients Undergoing Ovarian Stimulation: A German Fertility Database Study 307
Gene Expression and Apoptosis Levels in Cumulus Cells of Patients with Polymorphisms of FSHR and LHB Undergoing in Vitro Fertilization Program 304
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival 299
Comparative assessment of the structural features of human follicle-stimulating hormone in products from multiple markets 263
Exploring the human chorionic gonadotropin induced steroid secretion profile of mouse Leydig tumor cell line 1 by a 20 steroid LC-MS/MS panel 251
Reduced FSH and LH action: implications for medically assisted reproduction 231
Azione delle Gonadotropine sulle cellule target e relativa azione farmacologica nell'infertilità maschile: è tempo per l'azienda farmaceutica di cogliere la sfida? 224
Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis 208
Online comment by Batista et al. regarding article “Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection" 206
Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions 187
Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510) 183
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa(r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large German registry 183
In-depth glycosylation profiling of r-hFSH- α and r-hFSH- δ in comparison to human pituitary Follicle Stimulating Hormone 180
Biological Assay to Determine Gonadotropin Potency: From In Vivo to In Vitro Sustainable Method 179
Follicle-Stimulating Hormone Biological Products: Does Potency Predict Clinical Efficacy? 177
P-635 The impact of force-degraded variants of recombinant human follicle stimulating hormone alfa (r-hFSH alfa) on in-vitro and in-vivo biological activity 168
Comparison between follitropin-delta and follitropin-alfa for ovarian stimulation in context of ART is only scientifically sound and clinically relevant if individualization of starting dose is allowed in both arms! 167
Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models 161
Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin 157
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals 149
P-598 Dose accuracy of the follitropin-alfa, follitropin-alfa/lutropin-alfa and choriogonadotropin-alfa pen injectors used for fertility treatment 147
Use of a recombinant human follicle-stimulating hormone:recombinant human luteinizing hormone (r-hFSH:r-hLH) 2:1 combination for controlled ovarian stimulation during assisted reproductive technology treatment: A real-world study of routine practice in the Russian Federation 140
Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis (Reproductive Biology and Endocrinology, (2021), 19, 1, (51), 10.1186/s12958-021-00727-y) 132
Totale 5.705
Categoria #
all - tutte 24.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.127


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022195 0 0 0 0 4 6 3 6 4 77 38 57
2022/2023252 29 46 20 9 23 20 8 20 23 8 14 32
2023/2024393 6 11 22 52 46 27 62 48 27 18 17 57
2024/20251.250 35 6 64 68 201 249 70 60 108 43 179 167
2025/20262.339 150 127 227 264 244 112 294 116 249 213 200 143
2026/2027956 254 170 156 277 99 0 0 0 0 0 0 0
Totale 5.705